
Atrium Therapeutics, Inc.
USD12.17
-0.08 (-0.65%)
CEO
Kathleen Gallagher
IPO Date
2026-02-27
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$12.27
Prev. Close
$12.25
Day Low
$12.12
Day High
$12.39
52W Low
$11.95
52W High
$16.77
Market Cap
$0.21B
Volume
0.15M
| 28 Oct 2025 |
| Chardan Capital |
| Buy |
| Neutral |
| downgrade |
| 27 Oct 2025 | HC Wainwright & Co. | Buy | Neutral | downgrade |
| 27 Oct 2025 | Needham | Buy | Hold | downgrade |
| 27 Oct 2025 | Raymond James | Strong Buy | Market Perform | downgrade |
| 27 Oct 2025 | Leerink Partners | Outperform | Market Perform | downgrade |
| 27 Oct 2025 | Bernstein | Outperform | Market Perform | downgrade |
| 27 Oct 2025 | Citigroup | Buy | Neutral | downgrade |